MichaelJDetkeMDPhD

Psychopharmacology

Gereral outpatient part-time at Indiana University School of Medicine (Clinical Associate Professor)

Dr. Detke is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1996 - 2000
University of PennsylvaniaPhD, Psychology, 1988 - 1998
Perelman School of Medicine at the University of PennsylvaniaClass of 1996

PubMed

45 citations
Measures of outcome for stimulant trials: ACTTION recommendations and research agenda
Brian D. Kiluk, Kathleen M. Carroll, Amy M. Duhig, Daniel E. Falk, Kyle M. Kampman
Drug and Alcohol Dependence. 2016-01-01
5 citations
Comparison of Site-Based Versus Central Ratings in a Study of Generalized Anxiety Disorder.
Janet B. W. Williams, Kenneth A. Kobak, Earl L. Giller, David S. Reasner, Lisa Curry
Journal of Clinical Psychopharmacology. 2015-12-01
47 citations
A 6-week randomized, double-blind, placebo-controlled, comparator referenced trial of vabicaserin in acute schizophrenia
Joan H.Q. Shen, Yonggang Zhao, Sharon Rosenzweig-Lipson, Danielle Popp, Janet B. W. Williams
Journal of Psychiatric Research. 2014-06-01

Lighthouse Pharmaceuticals Announces Progression of LHP588 Clinical Development Program in Alzheimer's DiseaseMay 10th, 2023
Cortexyme, SQZ, Others Present New Insights into Alzheimer's and Parkinson'sMarch 21st, 2022
Cortexyme Provides New GAIN Trial Data at AD/PD 2022 Demonstrating Potential Benefit of Lysine Gingipain Inhibition in Mild to Moderate Alzheimer’s PopulationMarch 21st, 2022
Join now to see all